1. In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity
- Author
-
Lynn, GM, Laga, R, Darrah, PA, Ishizuka, AS, Balaci, AJ, Dulcey, AE, Pechar, M, Pola, R, Gerner, MY, Yamamoto, A, Buechler, CR, Quinn, KM, Smelkinson, MG, Vanek, O, Cawood, R, Hills, T, Vasalatiy, O, Kastenmueller, K, Francica, JR, Stutts, L, Tom, JK, Ryu, KA, Esser-Kahn, AP, Etrych, T, Fisher, KD, Seymour, LW, Seder, RA, Lynn, GM, Laga, R, Darrah, PA, Ishizuka, AS, Balaci, AJ, Dulcey, AE, Pechar, M, Pola, R, Gerner, MY, Yamamoto, A, Buechler, CR, Quinn, KM, Smelkinson, MG, Vanek, O, Cawood, R, Hills, T, Vasalatiy, O, Kastenmueller, K, Francica, JR, Stutts, L, Tom, JK, Ryu, KA, Esser-Kahn, AP, Etrych, T, Fisher, KD, Seymour, LW, and Seder, RA
- Abstract
The efficacy of vaccine adjuvants such as Toll-like receptor agonists (TLRa) can be improved through formulation and delivery approaches. Here, we attached small molecule TLR-7/8a to polymer scaffolds (polymer-TLR-7/8a) and evaluated how different physicochemical properties of the TLR-7/8a and polymer carrier influenced the location, magnitude and duration of innate immune activation in vivo. Particle formation by polymer-TLR-7/8a was the most important factor for restricting adjuvant distribution and prolonging activity in draining lymph nodes. The improved pharmacokinetic profile by particulate polymer-TLR-7/8a was also associated with reduced morbidity and enhanced vaccine immunogenicity for inducing antibodies and T cell immunity. We extended these findings to the development of a modular approach in which protein antigens are site-specifically linked to temperature-responsive polymer-TLR-7/8a adjuvants that self-assemble into immunogenic particles at physiologic temperatures in vivo. Our findings provide a chemical and structural basis for optimizing adjuvant design to elicit broad-based antibody and T cell responses with protein antigens.
- Published
- 2015